Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05713253 · ClinicalTrials.gov registry record · NA
A Phased, Prospective, Multi-center Study OF THE Elita System
A NA study, sponsored by Johnson & Johnson Surgical Vision.
- Terminated
- Registry status
- NA
- Development phase
- 96
- Enrollment target
NCT05713253: Clinical Trial NA study, sponsored by Johnson & Johnson Surgical Vision.
NCT05713253 is a NA study that was terminated before completion, run by Johnson & Johnson Surgical Vision. The registered enrollment target is 96 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05713253, a NA study, was terminated before completion, sponsored by Johnson & Johnson Surgical Vision.
- TERMINATED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
Study Summary
This study will be a 2-phase, prospective, multicenter, open-label, non-comparative, non-randomized clinical investigation to confirm the safety and effectiveness of the ELITA system.
Primary Outcome
The frequency, and proportion of eyes with each acuity line of monocular UCVA
Interventions
- DEVICE ELITA System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2023-02-02 |
| Est. Completion | 2025-02-21 |
| Phase | NA |
Why NCT05713253 stopped before completion
NCT05713253 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which ELITA System is the first listed.
NCT05713253 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05713253 about?
NCT05713253 is a clinical study titled "A Phased, Prospective, Multi-center Study OF THE Elita System". This study will be a 2-phase, prospective, multicenter, open-label, non-comparative, non-randomized clinical investigation to confirm the safety and effectiveness of the ELITA system.
What is the current status of trial NCT05713253?
This trial is currently terminated. It is a NA study. The enrollment target is 96 participants. The study started on 2023-02-02. Estimated completion is 2025-02-21.
What interventions are being tested in trial NCT05713253?
The interventions under investigation include: ELITA System (DEVICE).
Who is sponsoring clinical trial NCT05713253?
This trial is sponsored by Johnson & Johnson Surgical Vision, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05713253's enrollment target sits among peer trials
96 925th of 2000 higher than 1,070 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI